Leading with expertise and vision, our management team is dedicated to advancing pharmaceutical solutions, fostering innovation, and ensuring operational excellence to achieve impactful health outcomes worldwide.
Over 25 years of international experience in the biotechnology sector, spanning drug discovery, development, and investment.
Former CEO of Vesper Bio, where he advanced programs from discovery to clinical Phase II, and Board Director at Folium.
Previously Operating Partner at the Lundbeck Foundation, supporting and building innovative life science ventures across Europe.
Holds a PhD in Organic Chemistry from Cardiff University and a BSc in Chemistry from the University of Nottingham, and a Fellow of the Royal Society of Chemistry.
Nearly 25 years of experience in business development within small and mid-sized companies, combining strong operational leadership with strategic financial expertise
Extensive background as CFO and CEO across multiple industries, with hands-on experience from finance organizations and executive management teams in both listed and unlisted companies
Trained economist with deep competence in financial management, business analysis, and value creation, with a strong recent focus on start-ups and scale-ups
